163 related articles for article (PubMed ID: 11944578)
1. Familial clustering of end-stage renal disease in Mississippi.
Butkus DE
J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
[TBL] [Abstract][Full Text] [Related]
2. Familial clustering of end-stage renal disease in blacks with lupus nephritis.
Freedman BI; Wilson CH; Spray BJ; Tuttle AB; Olorenshaw IM; Kammer GM
Am J Kidney Dis; 1997 May; 29(5):729-32. PubMed ID: 9159307
[TBL] [Abstract][Full Text] [Related]
3. Family history of end-stage renal disease among hemodialyzed patients in Poland.
Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
[TBL] [Abstract][Full Text] [Related]
4. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
5. Familial aggregation of renal disease in a population-based case-control study.
Lei HH; Perneger TV; Klag MJ; Whelton PK; Coresh J
J Am Soc Nephrol; 1998 Jul; 9(7):1270-6. PubMed ID: 9644638
[TBL] [Abstract][Full Text] [Related]
6. Racial variation in autosomal dominant polycystic kidney disease.
Freedman BI; Soucie JM; Chapman A; Krisher J; McClellan WM
Am J Kidney Dis; 2000 Jan; 35(1):35-9. PubMed ID: 10620541
[TBL] [Abstract][Full Text] [Related]
7. The familial risk of end-stage renal disease in African Americans.
Freedman BI; Spray BJ; Tuttle AB; Buckalew VM
Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
[TBL] [Abstract][Full Text] [Related]
8. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
9. Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral.
Crook ED; Harris J; Oliver B; Fleischman E; Crenshaw G; Taylor R
J Investig Med; 2001 May; 49(3):284-91. PubMed ID: 11352187
[TBL] [Abstract][Full Text] [Related]
10. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
11. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
Spray BJ; Atassi NG; Tuttle AB; Freedman BI
J Am Soc Nephrol; 1995 Apr; 5(10):1806-10. PubMed ID: 7787148
[TBL] [Abstract][Full Text] [Related]
12. Incidence of glomerulonephritis and non-diabetic end-stage renal disease in a developing middle-east region near armed conflict.
Ali AA; Sharif DA; Almukhtar SE; Abd KH; Saleem ZSM; Hughson MD
BMC Nephrol; 2018 Oct; 19(1):257. PubMed ID: 30305040
[TBL] [Abstract][Full Text] [Related]
13. Family history of end-stage renal disease does not predict dialytic survival.
Freedman BI; Soucie JM; Kenderes B; Krisher J; Garrett LE; Caruana RJ; McClellan WM
Am J Kidney Dis; 2001 Sep; 38(3):547-52. PubMed ID: 11532687
[TBL] [Abstract][Full Text] [Related]
14. Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry.
Plantinga L; Lim SS; Patzer R; McClellan W; Kramer M; Klein M; Pastan S; Gordon C; Helmick C; Drenkard C
Arthritis Care Res (Hoboken); 2016 Mar; 68(3):357-65. PubMed ID: 26239749
[TBL] [Abstract][Full Text] [Related]
15. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB
Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638
[TBL] [Abstract][Full Text] [Related]
16. Anticipation of end stage renal disease in patients with autosomal dominant polycystic kidney disease in successive generations.
Sotirakopoulos N; Tsitsios T; Stambolidou M; Cristodoulidou C; Spaia S; Mavromatidis K
Ren Fail; 2001 Sep; 23(5):715-20. PubMed ID: 11725918
[TBL] [Abstract][Full Text] [Related]
17. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.
Bergman S; Key BO; Kirk KA; Warnock DG; Rostant SG
Am J Kidney Dis; 1996 Mar; 27(3):341-6. PubMed ID: 8604702
[TBL] [Abstract][Full Text] [Related]
18. Family history of end-stage renal disease among incident dialysis patients.
Freedman BI; Soucie JM; McClellan WM
J Am Soc Nephrol; 1997 Dec; 8(12):1942-5. PubMed ID: 9402097
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
20. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
